Peptide Therapy · Bonita Springs, Fl
Tesamorelin Therapy in Bonita Springs, FL
Physician-Supervised Visceral Fat Reduction & Metabolic Optimization
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), prescribed by Dr. Katherine Ortiz at DNA Wellness and Longevity Institute. It is the only peptide with FDA approval specifically for reducing excess visceral abdominal fat — the metabolically active deep belly fat linked to cardiovascular disease, insulin resistance, and metabolic syndrome — and is now used in broader metabolic optimization and longevity protocols for adults who haven't responded to diet and exercise alone.
Why patients choose us
Physician-Led
All protocols supervised by
Dr. Katherine Ortiz I-MD, Ph.D., PA-C, M.M.S., ABAAHP
Lab-Based
Protocol built from your bloodwork, not a template
SW Florida
Serving Bonita Springs, Naples, Estero & Fort Myers
Treatment Overview
Tesamorelin Therapy
Physician-Supervised
Lab-Based Protocol
FDA-Regulated
Bonita Springs, FL
What Is Tesamorelin?
How Tesamorelin Works
Tesamorelin is a synthetic 44-amino acid analog of human growth hormone-releasing hormone (GHRH), engineered with a structural modification at its N-terminal end that makes it significantly more resistant to enzymatic breakdown than naturally occurring GHRH — giving it a longer half-life and more consistent therapeutic effect. Like Sermorelin, it works by binding to GHRH receptors in the pituitary gland and stimulating your body's own pulsatile growth hormone release rather than introducing synthetic GH directly. The critical clinical distinction is its targeting: Tesamorelin has a particularly pronounced effect on visceral adipose tissue (VAT) — the deep abdominal fat that sits around organs and is metabolically distinct from subcutaneous fat.
Tesamorelin was FDA-approved in 2010 under the brand name Egrifta® for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy — making it the first and only FDA-approved therapy specifically indicated for visceral fat reduction. Clinical trials demonstrated an average 15–20% reduction in visceral adipose tissue after 26 weeks of treatment, along with meaningful improvements in waist circumference, triglyceride levels, and inflammatory markers. Beyond its approved indication, Tesamorelin is now used in functional and metabolic medicine settings for non-HIV patients with significant visceral adiposity, fatty liver concerns, or elevated cardiometabolic risk — evaluated on a case-by-case basis by a qualified clinician.
Dr. Ortiz integrates Tesamorelin into comprehensive metabolic and longevity protocols at DNA Wellness, always preceded by appropriate lab work and a thorough clinical evaluation. It is not a standalone weight loss solution — its most meaningful results come when paired with nutritional guidance, appropriate activity, and, where relevant, hormone optimization.
How It Helps
Potential Benefits of Tesamorelin Therapy
Visceral Fat Reduction
Visceral fat — the deep abdominal fat that surrounds organs — is metabolically far more dangerous than the subcutaneous fat you can pinch. It drives insulin resistance, systemic inflammation, elevated triglycerides, and cardiovascular risk in ways that body weight alone doesn't capture. Tesamorelin's most clinically documented effect is a significant, measurable reduction in visceral adipose tissue. Phase 3 randomized controlled trials demonstrated an average 15–20% reduction in VAT after 26 weeks, along with meaningful reductions in waist circumference — even in patients whose weight on the scale didn't change dramatically. For adults who carry stubborn central fat despite consistent diet and exercise effort, this targeted mechanism represents a meaningful clinical option.
Metabolic & Cardiometabolic Health
Visceral fat reduction isn't just aesthetic — it carries direct metabolic consequences. Clinical trials of Tesamorelin documented improvements in triglyceride levels, reductions in hepatic fat (non-alcoholic fatty liver disease is closely tied to visceral adiposity), and favorable changes in inflammatory markers. For patients Dr. Ortiz is already managing for insulin resistance, metabolic syndrome, dyslipidemia, or early cardiometabolic risk, Tesamorelin's targeted mechanism on visceral tissue offers a complementary intervention that works alongside lifestyle and hormone optimization rather than replacing them.
Body Composition, Energy & Healthy Aging
Because Tesamorelin stimulates pulsatile growth hormone release — the same GH that naturally declines with age — patients frequently report secondary benefits beyond visceral fat loss: modest improvements in lean muscle preservation, better energy, improved sleep quality, and a general sense of physical resilience. These effects align with what Dr. Ortiz observes across GH-stimulating peptide therapies at the clinic. Tesamorelin is therefore particularly well-suited for adults in their 40s and 50s who are managing both the metabolic and aging dimensions of abdominal weight gain simultaneously, and for whom a single targeted intervention addresses multiple underlying contributors at once.
Your Journey
What To Expect with Dr Ortiz
Step 01 — Metabolic Assessment & Lab Evaluation Your first appointment with Dr. Ortiz includes a comprehensive metabolic review — fasting glucose, insulin, triglycerides, IGF-1, thyroid panel, and where indicated, a DEXA scan or waist circumference measurement to establish a visceral fat baseline. This evaluation serves two purposes: confirming that Tesamorelin is clinically appropriate for your situation, and establishing the baseline metrics you and Dr. Ortiz will use to measure your response over time. Patients with active malignancy, pregnancy, or certain endocrine conditions may not be appropriate candidates — the assessment determines this clearly before any prescription is issued.
Step 02 — Personalized Protocol & Administration Tesamorelin is administered as a daily subcutaneous injection, typically into the abdominal area, on most days of the week per your prescribed protocol. Dr. Ortiz provides full injection training and sourced prescriptions from licensed U.S. compounding pharmacies. The most commonly reported side effects — joint discomfort, mild fluid retention, and injection site redness — are dose-related and typically manageable with protocol adjustment. Because Tesamorelin raises IGF-1 levels, Dr. Ortiz monitors this closely; patients with a personal or family history of malignancy require individualized risk discussion before starting.
Step 03 — Progress Monitoring & Optimization Meaningful visceral fat reduction with Tesamorelin typically becomes measurable at 8–12 weeks, with the most significant changes documented at 26 weeks in clinical trials. Dr. Ortiz schedules follow-up lab work at 8-week intervals to monitor IGF-1, metabolic markers, and your subjective response. Tesamorelin is most effective as part of a longer-term metabolic protocol — not a short course. Where appropriate, Dr. Ortiz integrates it with hormone optimization, dietary guidance, and other longevity interventions already underway.
Questions Answered
Frequently Asked Questions About Tesamorelin
Q1: How is Sermorelin different from HGH injections? Sermorelin does not introduce synthetic growth hormone into your body. Instead, it signals your pituitary gland to produce its own GH, preserving your body's natural feedback mechanism. This means your GH levels cannot climb beyond what your body's own regulatory system allows — an important safety distinction from direct HGH therapy.
Q2: Who is a good candidate for Sermorelin therapy? Sermorelin is most appropriate for adults over 30 who are experiencing symptoms consistent with age-related GH decline: fatigue that doesn't resolve with rest, difficulty maintaining muscle mass, increased body fat around the midsection, reduced exercise tolerance, or disrupted sleep. A comprehensive lab evaluation with Dr. Ortiz determines candidacy.
Q3: How long before I notice results from Sermorelin? Most patients notice improved sleep quality within the first 3–6 weeks. Energy, mood, and recovery typically improve over months 1–3. Body composition changes — leaner muscle, reduced fat — generally become measurable by months 3–6 with consistent therapy and appropriate lifestyle support.
Q4: How is Sermorelin administered, and is it difficult? Sermorelin is given as a small subcutaneous injection — similar to an insulin injection — typically in the abdomen or thigh before bed. Dr. Ortiz's team provides full training at your first treatment visit. Most patients are comfortable self-administering within a few days.
Q5: Is Sermorelin available in Bonita Springs and the surrounding area? Yes. DNA Wellness and Longevity Institute, located at 26800 S Tamiami Trail, Suite 380 in Bonita Springs, offers Sermorelin therapy for patients throughout Bonita Springs, Naples, Estero, Fort Myers, and Southwest Florida. Telehealth follow-up appointments may also be available.Q1: How is Tesamorelin different from Sermorelin? Both Tesamorelin and Sermorelin are GHRH analogs that stimulate pulsatile growth hormone release from the pituitary — but they differ in their structural design and clinical focus. Tesamorelin is a 44-amino acid peptide with a specific N-terminal modification that makes it more enzymatically stable, giving it a longer half-life and a more pronounced, well-documented effect on visceral adipose tissue specifically. Sermorelin is a shorter peptide (GHRH 1-29) with a broader range of GH-support benefits — energy, sleep, recovery, and general healthy aging. Dr. Ortiz determines which is more appropriate based on your primary goals and clinical picture. Some patients use both in a sequenced or combined protocol.
Q2: Is Tesamorelin FDA-approved? Tesamorelin (Egrifta®) is FDA-approved specifically for the reduction of excess visceral abdominal fat in adults with HIV-associated lipodystrophy — making it the only peptide with this specific regulatory indication. Its use in non-HIV patients with visceral adiposity, metabolic syndrome, or cardiometabolic risk is considered off-label, meaning it is prescribed based on clinical judgment, patient-specific risk-benefit analysis, and a growing body of metabolic research. Dr. Ortiz discusses this distinction transparently during your consultation.
Q3: Who is a good candidate for Tesamorelin therapy? Tesamorelin is most appropriate for adults with clinically meaningful visceral adiposity — particularly central abdominal fat that has not responded adequately to diet and exercise. Good candidates typically have evidence of elevated cardiometabolic risk, fatty liver concerns, or metabolic syndrome components alongside abdominal fat accumulation. Patients with active malignancy, uncontrolled diabetes, pregnancy, or certain pituitary or endocrine disorders are generally excluded. A comprehensive metabolic evaluation with Dr. Ortiz determines candidacy clearly before any prescription is issued.
Q4: How long does Tesamorelin take to work, and are results permanent? Clinical trials show meaningful visceral fat reduction beginning at 8–12 weeks, with the most significant results at 26 weeks of consistent therapy. An important clinical reality: visceral fat reduction with Tesamorelin is sustained only with continued therapy. Studies show that visceral fat tends to return toward baseline within several months of stopping treatment. This makes Tesamorelin most effective as part of a longer-term metabolic management strategy — not a short course — and is why Dr. Ortiz integrates it with lifestyle, nutritional, and hormone interventions designed to support lasting metabolic health.
Q5: Is Tesamorelin available in Bonita Springs and Southwest Florida? Yes. DNA Wellness and Longevity Institute, located at 26800 S Tamiami Trail, Suite 380 in Bonita Springs, offers physician-supervised Tesamorelin therapy for patients throughout Bonita Springs, Naples, Estero, Fort Myers, and surrounding Southwest Florida communities. Call (239) 250-7930 to schedule your metabolic consultation with Dr. Ortiz.
Meet Dr. Katherine Ortiz
Dr. Katherine Ortiz is the founder of DNA Wellness and Longevity Institute in Bonita Springs, FL. She is a board-certified Physician Associate and holds a Ph.D. in Integrative Medicine from Quantum University, with fellowship training through the American Academy of Anti-Aging Medicine (A4M) and the University of South Florida in functional and regenerative medicine.
Her practice is built on a foundational belief: that the body has an extraordinary capacity to heal and self-regulate when given the right support. Dr. Ortiz investigates root causes — hormonal imbalances, nutritional deficiencies, genetic factors — and builds individualized protocols designed to restore function and optimize long-term health.
Every protocol at DNA Wellness is ordered, reviewed, and monitored directly by Dr. Ortiz.
Ready to Address Visceral Fat With a Clinically Proven Approach?
Schedule a metabolic consultation with Dr. Katherine Ortiz at DNA Wellness and Longevity Institute in Bonita Springs. If stubborn abdominal fat hasn't responded to diet and exercise, there may be a physiological reason — and a targeted solution. Dr. Ortiz will review your metabolic labs and build a protocol grounded in your biology.
